Samrat Pharmachem P/B Ratio

Current P/B Ratio
1.18
Moderate Valuation
Moderate - Reasonably valued relative to book value

Samrat Pharmachem (SAMRATPH) P/B ratio is 1.18 (Moderate), book value per share ₹240.00 vs Healthcare average P/B of -0.3 — Moderate - Reasonably valued relative to book value. View SAMRATPH yearly price range for the annual high/low range and current price position.

Current Valuation Metrics

P/B Ratio 1.18
Current Price ₹286.60
Book Value/Share ₹240.00
Exchange BSE

Book Value Breakdown (2025)

Balance Sheet Components
Total Equity ₹72 Cr
Share Capital ₹3 Cr
Reserves & Surplus ₹69 Cr
Outstanding Shares 3,000,000
Book Value per Share ₹240.00

Valuation Signal

Signal Fairly Valued
Historical Avg 2.55
Historical Range 0.95 - 4.85
Percentile 20.0%

Sector Context

Sector Average -0.3
Sector Median 0.6
Sector Rank #11 of 50
Sector Percentile 22.0%

SAMRATPH P/B Ratio — Valuation Insights & Book Value Analysis

Samrat Pharmachem price-to-book ratio interpretation, valuation status and historical context — current P/B 1.18 (Moderate). Review SAMRATPH P/E comparison to evaluate earnings-based valuation against sector peers.

  • Current PB is 53.7% below historical average
  • Trading at premium to sector average PB of -0.3

Samrat Pharmachem P/B Ratio Historical Trend

SAMRATPH annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see SAMRATPH share price screener.

SAMRATPH Historical P/B Ratio — Book Value Per Share & Year-End Price

Samrat Pharmachem annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2025 0.95 ₹240.0 ₹227.30 ₹72 Low
2024 1.77 ₹216.67 ₹382.65 ₹65 Moderate
2023 1.66 ₹210.0 ₹348.20 ₹63 Moderate
2022 4.85 ₹156.67 ₹759.50 ₹47 High
2021 3.51 ₹100.0 ₹351.45 ₹30 High

SAMRATPH vs Healthcare Peers — P/B Ratio Comparison

Samrat Pharmachem P/B 1.18 vs Healthcare average -0.3, median 0.6 — range -16.4–1.11.

Sector Average
-0.3
Sector Median
0.6
Lowest P/B
-16.4
Highest P/B
1.11
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -16.4 ₹20 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Parmax Pharma PARMAX -4.18 ₹29 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.23 ₹73 Low
Krebs Biochemicals & Ind… KREBSBIO -0.79 ₹126 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.56 ₹50 Low